Media reports: UK Rx top-up ban set to end

3 November 2008

The ban on UK patients paying out-of-pocket for prescription drugs that are not covered by the National Health Service (Marketletters passim) looks set to be lifted, according to local media reports. Top-ups have existed for years, however, the Labour government last year allowed the NHS to deny treatment to people who obtained medicines privately. Health Secretary Alan Johnson will publish guidance from Michael Richards, the UK's "Cancer Czar," in early November, the Daily Telegraph reports.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight